Prevention of Cardiometabolic Disease in Familial Hypercholesterolemia
L’hypercholestérolémie familiale (FH) est un désordre lipidique associé aux maladies cardiovasculaires les plus fréquentes. La FH est causée par des mutations dans les gènes LDLR, APOB et PCSK9. Toutefois, chez 20% des patients souffrant de FH, aucune mutation dans ces gènes n'a été détectée et...
Main Author: | Awan, Zuhier |
---|---|
Other Authors: | Seidah, Nabil |
Language: | en |
Published: |
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/1866/10911 |
Similar Items
-
Prevention of Cardiometabolic Disease in Familial Hypercholesterolemia
by: Awan, Zuhier
Published: (2014) -
Prevalence and Impact of Apolipoprotein E7 on LDL Cholesterol Among Patients With Familial Hypercholesterolemia
by: Hayato Tada, et al.
Published: (2021-04-01) -
Genetic basis of index patients with familial hypercholesterolemia in Chinese population: mutation spectrum and genotype-phenotype correlation
by: Di Sun, et al.
Published: (2018-11-01) -
Endoplasmic reticulum quality control of LDLR variants associated with familial hypercholesterolemia
by: Praseetha Kizhakkedath, et al.
Published: (2019-11-01) -
The Digenic Causality in Familial Hypercholesterolemia: Revising the Genotype–Phenotype Correlations of the Disease
by: Amina Kamar, et al.
Published: (2021-01-01)